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Although an intimate relationship between 
members of the microbial fl  ora and the intesti-
nal epithelium has been documented, it is largely 
unknown how and to what extent the mucosal 
surface senses the presence of colonizing micro-
bial organisms and allows for innate immune 
receptor-mediated responses (1). Recognition 
of microbial structures by mammalian cells oc-
curs through various transmembrane receptor 
molecules that belong to the innate immune 
system. The Toll-like receptors (TLRs) recog-
nize conserved microbial structures such as LPS, 
mediate cellular activation, and thereby provide 
the costimulatory signal required for an effi   cient 
immune response (2). Epithelial cells derived 
from colonized mucosal surfaces were initially 
thought to be devoid of these potent immuno-
stimulatory receptors (3, 4). Later, TLR expres-
sion was also demonstrated on epithelial cells of 
the intestine and other tissues (5–8). However, 
functional studies were almost exclusively per-
formed using established epithelial cell lines 
  under conditions unable to refl  ect the complex 
environment in the gastrointestinal tract in vivo. 
Intact TLR signaling and microbial coloniza-
tion was shown to support wound healing of 
colonic mucosal lesions (9, 10). The responsible 
TLR4+ cell type was not identifi  ed, and recent 
work indicated intestinal macrophages as major 
players in colonic tissue repair (11). Thus, the 
characterization and functional relevance of TLR 
expression by the intestinal epithelium in vivo 
has remained unresolved.
In this study we investigated TLR4/MD-2 
expression and LPS-mediated signaling in highly 
enriched primary small intestinal epithelial cells 
(IECs) of fetal, newborn, and adult mice. We 
used fl   ow cytometry, intracellular chemokine 
staining, quantitative mRNA analysis, as well as 
stimulation assays to determine NF-κB activa-
tion, kinase activity, and chemokine synthesis in 
response to stimulation. We show that fetal, neo-
natal, and adult IECs express the TLR4/MD-2 
receptor complex but dramatically diff  er in their 
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shortly after birth as illustrated by phosphorylation of I𝗋B-𝗂 and nuclear translocation of 
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was associated with a posttranscriptional down-regulation of the interleukin 1 receptor–
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responsiveness to LPS. We describe for the fi  rst time the post-
natal process of epithelial tolerance acquisition and identify 
the responsible molecular mechanism. This adaptive process is 
unique to epithelial cells because intestinal macrophages exhi-
bited a constitutive, age-independent nonresponsive phenotype. 
The presented data support a new concept of the development 
of the enteric host–microbe homeostasis, which relies on 
postnatal acquisition of epithelial tolerance to microbial 
  ligands to facilitate intestinal bacterial colonization. More-
over, the described fi  ndings might have a substantial impact 
on the understanding of the molecular processes that mediate 
mucosal host defense during microbial infection and tissue 
repair in the gastrointestinal tract.
RESULTS
Primary IECs age-independently express 
the LPS receptor TLR4/MD-2
To analyze TLR expression and ligand susceptibility, primary 
IECs were prepared from small intestinal tissue of C57BL/6 
mice kept under specifi  c pathogen-free conditions. Using a 
modifi  ed protocol for the isolation of intact intestinal epithe-
lium, we were able to obtain viable, highly enriched prepara-
tions of diff  erentiated epithelial cells (12, 13). Isolated epithelial 
cell aggregates showed the morphological features of intact 
intestinal villi with attached crypts. Phalloidin staining visual-
ized apical actin fi  bers along the brush border microvilli (Fig. 
1 A). Immunostaining illustrated the polarized phenotype 
with apically orientated lateral zonula occludens protein 
(ZO)-1 staining and broad lateral E-cadherin expression (Fig. 
1 B). Viability and the absence of apoptosis in the majority of 
isolated IECs were confi  rmed by fl  ow cytometric propidium 
iodine exclusion and negative annexin V staining (Fig. 1 C). 
IEC preparations were of high purity and contained only 
minute fractions of hematopoietic cells, such as T cells, B cells, 
or dendritic cells (Fig. 1 D), which was a prerequisite for the 
subsequent structural and functional analysis.
For the analysis of intestinal TLR expression, we fi  rst used 
laser microdissection to obtain IECs in situ from fetal, new-
born, and adult enteric tissue. RT-PCR analysis revealed age-
independent expression of the LPS receptor complex TLR4 
and MD-2. Absence of contaminating TLR+myeloid cells in 
laser microdissection–derived epithelial cell preparations was 
shown by lack of CD45 expression (Fig. 2 A). Next, we pre-
pared primary IECs from fetal and adult intestinal tissue as 
  described above (Fig. 1), which were permeabilized and ana-
lyzed by fl  ow cytometry confi  rming the expression of TLR4/
MD-2. RAW 264.7 cells were used as a positive control (Fig. 
2 B). To confi  rm the epithelial nature of the TLR4+ cells, 
  simultaneous staining for TLR4 and the epithelial cell marker 
E-cadherin was performed and revealed a great majority of 
double-positive cells (Fig. 2 C). Thus, epithelial cells in the in-
testinal tract express the LPS receptor TLR4/MD-2 in vivo.
Whereas macrophages carry the LPS recognition complex 
on the cell surface membrane, localization of TLR4 to the in-
tracellular Golgi apparatus has been demonstrated in the IEC 
line m-ICcl2 (6). Immunostaining and fl  ow cytometric analysis 
of the same IEC preparations were performed under per-
meabilizing or nonpermeabilizing conditions to determine 
the cellular distribution of TLR4 in primary IECs. Peritoneal 
macrophages were used as control for cell surface localization. 
Whereas peritoneal macrophages exhibited strong cell surface 
staining for TLR4, the expression of TLR4 in viable primary 
IECs isolated from adult and fetal mice was clearly restricted to 
the intracellular space (Fig. 2 D). Because intracellular receptor 
localization would require ligand internalization, we next incu-
bated primary IECs in the presence of Salmonella typhimurium 
LPS at a concentration of 100 ng/ml for 30 min. Indeed, the 
presence of intracellular LPS could be demonstrated using 
monoclonal antibodies directed against the S. typhimurium LPS 
O4 and O5 antigen (Fig. 2 E). Thus, expression of TLR4 in 
viable primary IECs is restricted to an intracellular compart-
ment, and ligand internalization might facilitate stimulation as 
recently shown for intestinal epithelial m-ICcl2 cells (14).
IECs exhibit differential susceptibility to LPS depending 
on the developmental stage
To analyze whether IECs sense and respond to the presence 
of microbial ligands, we fi  rst tested the production of the 
Figure 1.  Characterization of primary IEC preparations. (A) Visual-
ization of isolated primary epithelial cell aggregates comprising intestinal 
villi with the attached crypts by phase contrast microscopy. Bar, 1 μm. 
Phalloidin staining of freshly isolated primary cells illustrating actin ac-
cumulation along apical microvilli. Bar, 30 μm. (B) Verifi  cation of the po-
larized phenotype of primary IECs by immunostaining for E-cadherin (left) 
and ZO-1 (right). The depicted images show a three-dimensional recon-
struction of the polarized, multicellular epithelial cell complex to illustrate 
the cellular structure. Bar, 10 μm. (C) Determination of cell viability and 
apoptosis of primary IECs by propidium iodine (PI) exclusion analysis and 
FITC–annexin V staining. (D) Staining for nonepithelial hematopoietic 
(CD45+) cells of a representative preparation of primary IECs using anti-
CD11b, anti-CD3, and anti-B220 antibodies.JEM VOL. 203, April 17, 2006  975
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proinfl  ammatory chemokines KC and macrophage infl  am-
matory protein 2 (MIP-2), functional murine homologues of 
the human IL-8. No chemokines were measurable in super-
natants of resting IECs isolated from adult mice. Also, stimu-
lation with LPS or the cytokines TNF or IL-1β did not result 
in detectable chemokine secretion (Fig. 3 A). This nonre-
sponsive phenotype could not be overcome by the addition 
of high concentrations of LPS (1–5 μg/ml; not depicted). In 
striking contrast, primary IECs from fetal intestinal tissue 
readily responded to LPS, IL-1β, or TNF with a signifi  cant 
increase of chemokine secretion (Fig. 3 B). Activation was 
seen with LPS concentrations as low as 10 ng/ml, illustrating 
the susceptibility of fetal primary cells to LPS. Although ex-
posure to other TLR ligands also resulted in cellular activa-
tion, LPS represented the most potent stimulus (not depicted). 
Primary IECs from newborn mice (1–6-d-old) exhibited 
spontaneous chemokine secretion, which, however, could 
not be enhanced by the addition of LPS or immunostimula-
tory cytokines (Fig. 3, C and D). Additionally, LPS and 
  cytokine-mediated phosphorylation of NF-κB signaling 
molecules were analyzed in fetal and adult primary IECs. 
Whereas rapid phosphorylation of IκB-α and the NF-κB 
subunit p65 was noted upon stimulation of fetal IECs with 
100 ng/ml LPS or 50 ng/ml TNF, IECs isolated from adult 
tissue were completely unresponsive (Fig. 3 E).
To exclude the possibility that the chemokines in the cul-
ture supernatant or the detected kinase activity might originate 
from minor hematopoietic contaminants within the epithelial 
cell preparation, intracellular chemokine staining was estab-
lished. Control experiments using naive or LPS-stimulated 
primary peritoneal macrophages confi   rmed the validity of 
the method for the detection of MIP-2 production (Fig. 4 A). 
Primary IECs prepared from late gestational fetuses (day −1), 
6-, or 28-d-old mice were incubated in the presence or ab-
sence of 100 ng/ml LPS, stained for intracellular MIP-2, and 
examined by FACS analysis (Fig. 4 B). Similar to the chemo-
kine secretion assays, MIP-2 production in nonstimulated cells 
was only observed in IECs from 6-d-old newborn mice, but 
not in cells from fetal or adult animals (Fig. 4 B, left column). 
In contrast, LPS exposure induced MIP-2 staining in primary 
IECs from fetal tissue, but not in IECs isolated from adult 
mice. No further increase of the spontaneous chemokine pro-
duction by LPS stimulation was detected in IECs isolated from 
6-d-old newborn mice (Fig. 4 B, right column). Finally, dou-
ble staining of 6-d-old newborn IECs for E-cadherin and in-
tracellular MIP-2 unequivocally demonstrated that IECs were 
the source of chemokine production (Fig. 4 C). This was also 
confi  rmed by immunofl  uorescence visualizing MIP-2+ cellu-
lar compartments in E-cadherin+ primary IECs (Fig. 4 D). In 
conclusion, fetal but not adult IECs exhibit susceptibility to 
Figure 2.  Intracellular LPS receptor expression by primary IECs. 
(A) RT-PCR analysis for TLR4 and MD-2 expression in intestinal epithelium 
from fetal, 1-, and 6-d-old newborn as well as adult intestinal tissue 
  obtained by laser microdissection. Detection of CD45 expression was used 
to demonstrate the absence of myeloid cells in the dissected tissue. 
  Macrophage-like RAW 264.7 cells were used as positive control for CD45 
expression. β2-microglobulin (β2m) expression was used as a housekeep-
ing control. The hematoxylin-stained tissue section illustrates the micro-
dissection procedure. Bar, 500 μm. (B) FACS analysis of isolated primary 
IECs from fetal (day −1) and adult (day 28) murine intestine for the ex-
pression of the LPS receptor complex TLR4/MD-2. RAW 264.7 cells were 
used as positive control. Dotted line, isotype control. (C) FACS analysis 
using double immunostaining of primary IECs for isotype antibodies (left) 
or TLR4/MD-2 and E-cadherin (right) to confi  rm epithelial TLR4 expression. 
Primary IECs were isolated from 6-d-old mice. (D) Staining of murine peri-
toneal macrophages as well as primary IECs isolated from adult (day 28) 
and fetal (day −1) intestinal tissue for TLR4/MD-2 with or without per-
meabilization of the cellular membrane to illustrate surface TLR expres-
sion. Dotted line, isotype control. (E) LPS internalization of primary IECs. 
Cells were incubated in the presence of 100 ng/ml S. typhimurium LPS and 
immunostained using two monoclonal antibodies directed against the LPS 
O-antigen. Counterstaining with FITC-phalloidin and DAPI. Bar, 20 μm.976  ENTERIC EPITHELIAL TLR RECOGNITION | Lotz et al.
LPS stimulation and IECs isolated from newborn mice show 
spontaneous activation.
Intestinal macrophages are constitutively 
nonresponsive to LPS
Resident intestinal macrophages from adult patients do not 
release proinfl  ammatory mediators in response to microbial 
stimulation (15). To examine whether intestinal macro-
phages similar to IECs acquire nonresponsiveness only after 
birth, we analyzed the secretion of proinfl  ammatory cyto-
kines as well as the expression of costimulatory molecules on 
isolated fetal, neonatal, and adult CD45+ and BM8+ primary 
intestinal macrophages (Fig. 5 A). Flow cytometric analysis 
of the costimulatory activation markers CD40 and B7.1 
(CD80) on intestinal macrophages from fetal, 1-, 3-, and 28-
d-old mice revealed no postnatal up-regulation (Fig. 5 B). 
Also, in vitro stimulation of fetal intestinal macrophages with 
LPS did not lead to signifi  cant up-regulation of CD40 or 
B7.1, whereas strong up-regulation of both markers was 
noted after stimulation of the macrophage-like cell line 
RAW 264.7 (Fig. 5 C). Finally, LPS stimulation of blood 
monocytes, but not of fetal intestinal macrophages, revealed 
secretion of signifi  cant levels of the proinfl  ammatory cyto-
kines MIP-2 and TNF (Fig. 5, D and E). Thus, in contrast 
to IECs that acquire LPS resistance only during the course of 
a postnatal activation process, intestinal macrophages exhibit 
a constitutive nonresponsiveness to LPS that refl  ects  the 
  infl  uence of tissue origin.
Intestinal epithelial activation occurs in vivo immediately 
after birth
Shortly after birth, the sterile body surfaces of the newborn 
become exposed to organic substances from the microbially 
colonized environment. Also, we have shown that IECs 
from newborn mice spontaneously release infl  ammatory 
chemokines (see Fig. 3 C). To further delineate the mecha-
nistic basis and kinetics of this transient activation, RNA 
was isolated from mice before and 1, 3, 6, and 15 d after 
birth and quantitatively analyzed for the presence of MIP-2 
mRNA. A transient three- to fourfold increase of MIP-2 
expression was seen in the total RNA isolated from the small 
intestine at the fi  rst day of life (Fig. 6 A). This mRNA in-
duction was signifi  cantly more pronounced in isolated IECs 
than in total small intestine, identifying IECs as a primary 
source of mRNA synthesis (Fig. 6 B). To identify the exact 
time point of maximal epithelial stimulation, RNA was har-
vested from the small intestine of littermates at 0, 1, 2, 4, and 
6 h after birth. Strikingly, quantitative MIP-2 mRNA analy-
sis revealed a maximal increase at 2 h after birth followed 
by rapid normalization within 6 h (Fig. 6 C). To confi  rm the 
time course and verify transcriptional activation of the epi-
thelium, the cellular localization of the NF-κB subunit p65 
as well as phosphorylation of IκB-α were analyzed in situ by 
immunostaining of intestinal tissue obtained shortly after 
natural delivery. Indeed, whereas p65 localized to the cyto-
plasma directly after birth, nuclear translocation of p65 was 
detected in situ in IECs within 60 min after delivery (Fig. 
6 D). Also, phosphorylation of IκB-α was detected in IECs 
45 and 60 min after birth (Fig. 6 E). Although cellular activa-
tion as refl  ected by transcriptional up-regulation and protein 
synthesis of the chemokine MIP-2 revealed a potent immuno-
stimulation, no increase of CD45+ infl  ammatory cells in 
  intestinal tissue was noted after birth (Fig. 6 F). Thus, a 
strong, self-limited transcriptional activation of IECs was ob-
served in neonatal mice shortly after birth in the absence of 
an infl  ammatory reaction.
Postnatal epithelial activation depends on exogenous 
microbial ligand exposure
To analyze the potential impact of exogenous microbial 
  ligands for the observed postnatal epithelial activation, we 
compared vaginally born neonatal mice with mice that 
were delivered by Caesarean section and not exposed to 
maternal body fl  uids or environmental stimuli. Strikingly, 
postnatal epithelial MIP-2 induction was only detected in 
naturally born mice but completely absent in 2-h-old neonatal 
mice that were delivered by Caesarean section and kept 
separately from adult animals (Fig. 7 A). To quantitatively 
analyze the concentrations of microbial ligands in   intestinal 
Figure 3.  Stimulation of isolated primary IECs. MIP-2 and KC con-
centrations in the cell culture supernatant of primary IECs isolated from 
adult mice (day 28; A), late gestational fetuses (day −1; B), newborn mice 
(day 1; C), or 6-d-old mice (D). Cells were stimulated with 1 or 10 ng/ml 
LPS, 100 ng/ml IL-1β, or 50 ng/ml TNF for 12 h. Values are presented as 
means ± SD. *, P < 0.05; **, P < 0.01. (E) Immunoblot analysis of p65 
and IκB-α phosphorylation in primary IECs isolated from fetal (day −1) 
or adult (day 28) mice 10, 20, 40, and 60 min after stimulation with 100 
ng/ml LPS or 50 ng/ml TNF. Equal sample loading is illustrated by actin 
and total p65 staining.JEM VOL. 203, April 17, 2006  977
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tissue, a sensitive colorimetric limulus-endotoxin test was 
performed. Considerable endotoxin concentrations (nano-
grams per gram tissue) were measured in homogenates of 
neonatal intestine shortly after birth (Fig. 7 B). As a possible 
source for microbial ligands, the gastrointestinal tract of 
adult animals was also examined and exhibited dramatic 
amounts of biologically active endotoxin (Fig. 7 C). To 
verify the role of exogenous microbial ligands, we next 
  exposed Caesarean-born neonates orally to low amounts of 
endotoxin. Indeed, oral exposure to LPS evoked a rapid 
increase of MIP-2 mRNA in the intestinal tissue of Caesar-
ean-born neonates, similar to the situation in vaginally born 
mice (Fig. 7 D). Thus, LPS alone is able to evoke IEC 
stimulation. To evaluate the contribution of LPS for epi-
thelial activation in vivo, we further analyzed mice defi  -
cient in TLR4. Surprisingly, lack of TLR4 resulted in an 
almost complete lack of epithelial activation (Fig. 7 E). 
Thus, the observed postnatal epithelial stimulation depends 
on vaginal delivery, oral exposure to endotoxin, and the 
presence of TLR4.
Postnatal activation is controlled by posttranscriptional 
down-regulation of IL-1 receptor–associated 
kinase 1 (IRAK-1)
Both the rapid normalization of transcriptional cell activation 
as well as the lack of infl  ammatory tissue infi  ltration prompted 
us to analyze the involvement of known negative regulators 
of TLR signaling. We fi  rst screened for a postnatal up-regulation 
of Sigirr and ST-2 expression as well as for the appearance 
of the diff  erentially spliced short form of MyD88 (sMyD88) 
(16–18). All three membrane proteins exert their inhibitory 
function by interaction with proximal signaling molecules of 
the IL-1R/TLR signaling pathway. Constitutive expression 
of Sigirr and ST-2 mRNA was detected in epithelial cells 
obtained by laser microdissection (not depicted). Also, no 
transcript of sMyD88 could be amplifi  ed from neonate intes-
tinal tissue (not depicted). The cytoplasmic protein Tollip has 
been shown to interact with MyD88 and is the only inhibi-
tory molecule known to exert a negative regulatory eff  ect 
on TLR signaling in epithelial cells (19). However, Tollip 
mRNA levels in intestinal tissue remained unchanged during 
the postnatal period. Also, the amount of Tollip protein 
  detected in fetal and neonatal intestinal tissue or the corre-
sponding isolated IECs remained unchanged after birth (not 
depicted). Finally, whereas Tollip was up-regulated by LPS 
stimulation of RAW 264.7 cells, no increase was found 
in mouse intestinal epithelial m-ICcl2 cells (not depicted). 
Thus, none of the transcriptionally regulated inhibitory 
  molecules could be identifi  ed to play a signifi  cant role in 
postnatal   epithelial tolerance.
Transient posttranscriptional down-regulation of the 
TLR signaling molecule IRAK-1 has been associated with 
acquired hyporesponsiveness in macrophages (20–22). How-
ever, IRAK-1 levels in total intestinal tissue of fetal and 
  postnatal tissue remained unchanged (not depicted). Surpris-
ingly, evaluation of isolated primary IECs demonstrated rapid 
Figure 4.  Transient postnatal activation and LPS susceptibility of 
primary IECs. (A) Characterization of intracellular MIP-2 staining using 
nonactivated or LPS (100 ng/ml) -stimulated peritoneal macrophages. 
(B) Intracellular MIP-2 staining of primary IECs isolated from late gesta-
tional fetal, 6-, and 28-d-old mice. MIP-2 was cytometrically analyzed after 
6 h of incubation in the presence of brefeldin A under nonstimulating con-
ditions or after the addition of 100 ng/ml LPS. Dotted line, isotype control. 
(C) Double immunostaining and FACS analysis of primary IECs from 6-d-old 
mice with MIP-2 and E-cadherin to identify spontaneous MIP-2 production 
in IECs. (D) MIP-2 (red) in IECs from 6-d-old mice was detected by intracel-
lular staining with a rabbit anti–MIP-2 antiserum (MIP-2) or an irrelevant 
affi  nity-purifi  ed rabbit control serum after incubation for 6 h in the pres-
ence of 0.5 μg/ml brefeldin A. Isolated IECs were identifi  ed as epithelial 
cells by E-cadherin staining (green). Counterstaining with DAPI. Bar, 20 μm.978  ENTERIC EPITHELIAL TLR RECOGNITION | Lotz et al.
down-regulation of IRAK-1 protein after birth, whereas the 
IRAK-1 mRNA expression remained stable throughout the 
examined time course (Fig. 8, A and B). IRAK-1 down-
  regulation was confi  rmed by immunostaining of IRAK-1 in 
fetal and postnatal intestinal tissue (Fig. 8 C). Similar to pri-
mary IECs, a poststimulatory depletion of IRAK-1 was also 
found in macrophage-like RAW 264.7 cells (Fig. 8 D) and 
even more pronounced in intestinal epithelial m-ICcl2 cells 
(Fig. 8, E and F). In accordance with recent results obtained 
studying myeloid cells, preincubation of IECs with the kinase 
inhibitor K-252b inhibited IRAK-1 degradation (Fig. 8 G; 
reference 23). In addition, ubiquitination of IRAK-1 was 
  detected in LPS-exposed ubiquitin-overexpressing m-ICcl2 
cells by immunoprecipitation (Fig. 8 H). Together, posttran-
scriptional down-regulation of IRAK-1 in response to micro-
bial stimulation was observed in IECs and might be responsible 
for the rapid termination of postnatal epithelial cell activation 
and thereby prevent prolonged chemokine production and 
the attraction of professional   immune cells.
IRAK-1 is essential for epithelial TLR4 signaling, 
and down-regulation contributes to endotoxin tolerance
A role of IRAK-1 for impaired IL-1R/TLR and TNF 
  receptor signaling has previously been shown in IRAK-1–
defi  cient mice and isolated macrophages (24–27). However, 
the general hyporesponsive phenotype of IRAK-1–defi  -
cient mice precluded their use for the analysis of the role of 
IRAK-1 for the acquisition of epithelial tolerance in vivo. 
Therefore, we resorted to an in vitro model of tolerance 
  induction using diff  erentiated intestinal m-ICcl2 epithelial 
cells (6). As seen before, LPS stimulation of nontransfected 
or mock-transfected m-ICcl2 cells conferred nonresponsive-
ness to a second LPS stimulus (Fig. 9 A). When a dominant-
negative construct of IRAK-1 was transfected into LPS-
susceptible m-ICcl2 cells before LPS stimulation, a substantial 
reduction of LPS-induced MIP-2 secretion was noted that 
was in accordance with the 30–40% transfection effi   ciency 
obtained in m-ICcl2 cells (Fig. 9 A). Cotransfection of an 
NF-κB luciferase reporter construct together with the 
dominant-negative form of IRAK-1 resulted in an even 
more pronounced reduction of cellular activation (Fig. 9 
B). In addition, the eff  ect of overexpression of IRAK-1 on 
the susceptibility of tolerant m-ICcl2 cells was evaluated. 
Whereas nontransfected or mock-transfected cells exhibited 
signifi  cantly reduced LPS sensitivity after LPS tolerization, 
overexpression of IRAK-1 in tolerant cells almost com-
pletely rescued LPS susceptibility (Fig. 9 C). The restored 
responsiveness to LPS was accompanied by detectable 
amounts of IRAK-1 in cell lysate (Fig. 9 D). Finally, the ef-
fect of IRAK-1 overexpression on NF-κB p65 transloca-
tion in tolerant m-ICcl2 cells was analyzed on the cellular 
level. Whereas tolerant cells exhibited a strongly reduced 
LPS susceptibility as compared with naive cells, intact nu-
clear translocation of p65 was observed in tolerant cells 
overexpressing IRAK-1 (Fig. 9 E). Thus, IRAK-1 plays an 
essential role during LPS activation of IECs, and lack of 
IRAK-1 in tolerant cells signifi   cantly contributes to the 
LPS-resistant phenotype.
DISCUSSION
TLR-mediated recognition of conserved microbial structures 
and ligand-induced cellular activation was fi  rst discovered 
Figure 5.  Constitutive LPS resistance of intestinal macrophages. 
(A) Characterization of the isolated intestinal macrophage preparation by 
CD45 (top) and BM8 (bottom) expression. (B) Analysis of surface B7.1 (top) 
and CD40 (bottom) expression on intestinal macrophages from fetal (bold), 
1- (normal), 3- (thin), and 28-d-old (dotted line) mice. (C) B7.1 (top) and CD40 
(bottom) expression on fetal intestinal macrophages (left) and RAW 264.7 
cells (right) after overnight incubation in the absence or presence of 100 ng/ml 
LPS. MIP-2 (D) and TNF (E) secretion by blood monocytes and intestinal mac-
rophages from fetal mice after overnight stimulation with LPS, 100 ng/ml 
IL-1β, 50 ng/ml TNF, and phorbol ester (5 μM PMA). *, not detectable.JEM VOL. 203, April 17, 2006  979
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on professional immune cells such as macrophages and 
  dendritic cells that reside in largely sterile tissue environ-
ments (27). The situation on epithelial surfaces, however, is 
markedly diff  erent. The intestinal tract is exposed to a variety 
of environmental microbial ligands and is colonized by a 
dense, complex, and highly dynamic microbial fl  ora that 
contributes to the intestinal physiology by substrate degra-
dation and synthesis of essential nutrients (28). The compo-
sition of the   microbial fl  ora is complex and provides most of 
the identifi  ed innate immune receptor ligands such as LPS 
at high   concentrations. Thus, innate immune recognition 
within the gastrointestinal tract must be tightly regulated to 
avoid inappropriate stimulation.
The vast majority of previous studies on TLR-mediated 
recognition by epithelial cells have been performed using esta-
blished cell lines under cell culture conditions and resulted in 
a heterogenous picture of TLR expression and ligand suscep-
tibility (29). In contrast, the use of mouse chimera with mye-
loid cell–restricted TLR expression indicated an important 
contribution of lung and bladder epithelial cells for the TLR4-
mediated host microbe interaction (30, 31). In the present 
study, we performed a detailed in vivo characterization of 
primary IECs within their complex natural environment by 
using laser microdissection, immunohistology, as well as ex 
vivo assays with isolated epithelial cells. LPS stimulation of 
fetal IECs in vitro readily resulted in intracellular cell signal-
ing, transcriptional activation, as well as chemokine synthesis 
and secretion. However, LPS susceptibility of IECs was lost 
after birth, indicating perinatal induction of negative regula-
tory control mechanisms of epithelial TLR signaling. This 
unique adaptive phenotype of epithelial cells with a postnatal 
acquisition of TLR resistance is further illustrated by the 
strikingly diff  erent situation found in intestinal macrophages. 
Intestinal macrophages exhibited a constitutive, age-indepen-
dent nonresponsive phenotype that appears to be causally 
  related to their tissue localization. Therefore, the observed 
postnatal activation represents a previously unrecognized 
  epithelium-specifi  c adaptive process that might play an im-
portant role to facilitate postnatal microbial colonization and 
establishment of a stable homeostasis on intestinal surfaces.
Figure 6.  Time course of postnatal IEC activation. (A) Quantitative 
MIP-2 mRNA analysis in total small intestinal tissue from fetal, 1-, 3-, 6-, 
and 15-d-old mice. HPRT expression was used for normalization. Values 
are presented as RQ ± RQ maximum and minimum, respectively, and 
indicate MIP-2 mRNA expression relative to the fetal tissue sample. 
(B) Quantitative MIP-2 mRNA analysis in isolated primary IECs from fetal, 
1-, 3-, and 6-d-old mice. (C) Quantitative MIP-2 mRNA analysis in total 
small intestinal tissue 0, 1, 2, 4, and 6 h after birth. (D) Immunostaining 
of neonatal small intestinal tissue obtained 0 and 60 min after delivery. 
The arrows indicate the cytoplasmic (0 min) or nuclear (60 min) cellular 
distribution of the NF-κB subunit p65. A secondary antibody control 
  illustrates the specifi  city of the immunostaining. Counterstaining with 
DAPI. Bar, 50 μm. (E) Immunostaining for phosphorylated IκB-α in neo-
natal small intestinal tissue obtained 0, 45, and 60 min after delivery. 
Counterstaining with hematoxylin. Bar, 100 μm. (F) Immunostaining of 
small intestinal tissue from 1-, 6-, and 28-d-old mice for the presence of 
CD45+ (green) immune cells. Counterstaining with TRITC-phalloidin. 
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Consistent with the LPS-susceptible phenotype of fetal 
IECs, exposure to the nonsterile environment after birth led 
to activation of the intestinal epithelium. However, the rapid, 
strong, and transient response observed in vivo within 2 h 
  after birth was unexpected. In fact, nuclear translocation of 
the NF-κB subunit p65 was observed already at 60 min after 
birth, indicating stimulation in close context with the deliv-
ery process. Analysis of neonates born by Caesarean section 
suggested an exogenous stimulus. LPS measurements in new-
born intestinal tissue, the stimulatory eff  ect of oral LPS expo-
sure in Caesarean-born neonates, as well as the absence of 
epithelial activation in TLR4-defi  cient mice fi  nally identifi  ed 
LPS as the major microbial stimulus for postnatal epithelial 
activation. The high concentrations of biologically active en-
dotoxin in intestinal and fecal samples of adult animals illus-
trated the minute volumes of ingested contaminated material 
required to evoke stimulation. However, although clearly 
the predominant stimulus, endotoxin might act in synergism 
with other microbial compounds in vivo. It is tempting to 
speculate that the observed postnatal epithelial activation 
might also occur on other epithelial body surfaces and could 
be involved in the up-regulation of host defense molecules to 
prepare for subsequent microbial exposure.
The activation of IECs after birth showed a self-limited 
time course with MIP-2 mRNA levels returning to baseline 
within only 4–6 h after delivery and no detectable proinfl  am-
matory tissue infi  ltration. Thus, the observed epithelial stim-
ulation induced a potent negative regulatory mechanism that 
caused rapid termination of cellular activation and induced 
unresponsiveness to subsequent stimulation. Posttranscrip-
tional down-regulation of IRAK-1 was detected selectively 
in primary IECs shortly after birth, and in vitro studies using 
diff  erentiated intestinal epithelial m-ICcl2 cells suggested that 
posttranscriptional depletion of IRAK-1 might signifi  cantly 
contribute to the observed LPS nonresponsive phenotype of 
primary postnatal IECs. IRAK-1 together with IRAK-4 
binds to the TLR/adaptor molecule complex and transmits 
the signal to the TNF receptor–associated factor 6 to facilitate 
NF-κB activation (32). The important role of IRAK-1 for 
IL-1 receptor/TLR-mediated signaling has been demon-
strated using IRAK-1–defi  cient mice (24–26, 33). Interest-
ingly, earlier work also revealed an important role of IRAK-1 
for TNF receptor signaling (27). Although IRAK-1 down-
regulation upon LPS stimulation has previously been noted 
in macrophages, our study is the fi   rst report to identify 
IRAK-1 depletion in epithelial cells as a mechanism of TLR 
hyporesponsiveness in vivo (20–22).
A recent study demonstrated that large amounts of LPS 
given orally induced intestinal pathology with signifi  cant 
mortality in fetal and newborn rats, but not in older animals 
(34). LPS susceptibility of fetal IECs has also been observed 
in humans (35, 36). Thus, postnatal epithelial activation 
might also occur in humans, and dysfunction of negative 
  regulation and tolerance acquisition, e.g., in undiff  erentiated 
enterocytes, or increased stimulation by enhanced stimulus 
concentration might lead to the development of enteric 
  infl  ammation. A corresponding clinical picture is seen in 
  patients with necrotizing enterocolitis (NEC), a devastating 
infl  ammatory disease of the intestine frequently seen in pre-
mature newborns. NEC is characterized by enteric cytokine 
production, polymorphonuclear cell (PMN) activation,   tissue 
infi  ltration, ischemic hemorrhage, and high mortality (37). 
Microbial colonization, enteral feeding, hyperresponsiveness 
of immature enterocytes, and uncontrolled cytokine produc-
tion have been proposed to contribute to the pathogenesis of 
this disease, although its exact etiology has remained unclear 
(38). Our data suggest that dysregulation of the observed 
postnatal proinfl  ammatory epithelial activation might partici-
pate in the pathogenesis of NEC.
In conclusion, this study provides conclusive evidence 
that primary IECs express TLR4 and are able to respond to 
LPS in vivo. It is the fi  rst to describe spontaneous postnatal 
epithelial cell activation induced by exogenous endotoxin 
and identifi  es posttranscriptional down-regulation of IRAK-1 
as a negative regulatory mechanism of TLR4 signaling in 
IECs in vivo. This adaptive process might be crucial to 
Figure 7.  Characterization of the stimulus of postnatal epithelial 
activation. (A) Quantitative MIP-2 mRNA analysis in total small intestinal 
tissue of newborn mice 0 and 2 h after vaginal delivery or Caesarean sec-
tion. #1 and #2 identify individual mice examined. (B) LPS concentration 
in total small intestinal homogenate of normally delivered newborn mice 
at the indicated time after birth. (C) LPS concentration in intestinal con-
tent and fecal samples of adult mice (n = 4). (D) Quantitative MIP-2 
mRNA analysis in total small intestinal tissue of fetal or neonatal mice 
born by Caesarean section 3 h after oral exposure to LPS at the indicated 
concentrations. (E) Quantitative MIP-2 mRNA analysis in total small intes-
tinal tissue of wild-type as well as TLR4-defi  cient newborn mice after 
vaginal delivery.JEM VOL. 203, April 17, 2006  981
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  facilitate postnatal microbial colonization and subsequent 
  development of the astonishingly stable, lifelong symbiosis. 
The fi  nding that epithelial unresponsiveness of postnatal IECs 
is not intrinsically determined, but acquired, illustrates the 
requirement for eff  ective negative regulatory mechanisms of 
innate immune recognition by IECs to prevent infl  ammatory 
disease. In addition, the newly discovered epithelial activation 
shortly after birth might pose a signifi  cant risk for individuals 
Figure 8.  Postnatal depletion of IRAK-1 in IECs. (A) Immunoblot for 
IRAK-1 in primary IECs isolated from fetal (day −1), 1-, 3-, and 6-d-old 
mice. A secondary antibody control was included to demonstrate the 
specifi  city of the IRAK-1 staining. Actin was included as loading control. 
(B) Analysis of IRAK-1 expression in LMD-isolated primary IECs. HPRT was 
included as housekeeping control. (C) Immunostaining for IRAK-1 in small 
intestinal tissue of fetal (day −1), 1-, and 6-d-old mice. A peptide control 
illustrates the specifi  city of the immunstaining. Counterstaining with 
DAPI. Bar, 100 μm. (D–F) Immunoblot for IRAK-1 in macrophage-like RAW 
264.7 cells and mouse intestinal epithelial m-ICcl2 cells at the indicated 
time points (hours) after exposure to 100 ng/ml LPS. (G) Immunoblot for 
IRAK-1 in mouse intestinal epithelial m-ICcl2 cells 2 h after exposure to 
100 ng/ml LPS in the absence or presence of 25 μM of the kinase inhibitor 
K-252b. Actin was included as loading control. (H) Immunoblot for IRAK-1 
in mouse intestinal epithelial m-ICcl2 cells left untreated or stimulated 
with 100 ng/ml LPS for 6 h (left). m-ICcl2 cells transfected with an ubiqui-
tin expression plasmid and stimulated with 100 ng/ml LPS for 0 or 0.5 h 
were immunoprecipitated using a polyclonal anti-ubiquitin antibody and 
immunoblotted to visualize IRAK-1 (right). Note the size difference 
  between native and ubiquitinated IRAK-1. HC, heavy chain; LC, light chain.
Figure 9.  Role of IRAK-1 in epithelial TLR4 signaling and endo-
toxin tolerance. (A) MIP-2 secretion of intestinal epithelial m-ICcl2 cells 
transfected with a control plasmid or a dominant-negative construct of 
IRAK-1. Cells were initially incubated in the presence or absence of 1 μg/ml 
LPS for 6 h, recovered for 36 h in LPS-free medium, and restimulated with 
100 ng/ml LPS for 6 h. (B) Cotransfection of a dominant-negative version 
of IRAK-1 with an NF-κB luciferase reporter construct. Luciferase produc-
tion in response to LPS stimulation of naive and LPS-tolerant cells carrying 
a control plasmid or a dominant-negative construct of IRAK-1. (C) Re-
stored LPS responsiveness of tolerant epithelial cells by overexpression of 
IRAK-1. Naive and tolerant m-ICcl2 cells were left untreated or transfected 
with a control or IRAK-1 expression construct before second stimulation. 
Signifi  cant reduction (P < 0.01) of MIP-2 secretion in tolerant cells was 
observed in mock or pFlag-transfected but not in pIRAK-1–transfected 
cells. (D) Immunoblot demonstrating IRAK-1 levels in naive cells as well as 
in tolerant mock-, pFlag-, and pIRAK-1–transfected cells. (E) Immuno-
staining for the NF-κB subunit p65 (red) showing nuclear translocation in 
naive cells as well as pIRAK-1–transfected (green) tolerant cells in 
  response to LPS stimulation. n.s., not signifi  cant. Counterstaining with 
DAPI. Bar, 40 μm.982  ENTERIC EPITHELIAL TLR RECOGNITION | Lotz et al.
who are unable to mount an adequate negative regulatory 
control. The further elucidation of the described tolerance 
acquisition process and characterization of all regulatory 
mechanisms involved will certainly help to reveal a more 
  detailed picture of innate immune recognition within the 
gastrointestinal tract and its possible role in the pathogenesis 
of infl  ammatory diseases.
MATERIALS AND METHODS
Antibodies and reagents. Rat monoclonal anti-TLR4/MD-2 antibodies 
(MTS510) and mouse monoclonal antibodies to Salmonella O4 and O5 
  antigen were generously provided by K. Miyake (Saga Medical School, 
  Nabeshima, Saga, Japan) and M. Kim (Kim Laboratories Inc.), respectively. 
Rabbit anti–MIP-2 antiserum was purchased from Nordic Biosite. The 
mouse monoclonal anti-phospho–IκB-α (Ser32/36) antibody and the rabbit 
polyclonal anti-phospho–NF-κB p65 (Ser536) antibody were from Cell Sig-
naling Technology, and the rabbit polyclonal anti-actin antiserum was from 
Sigma-Aldrich. The mouse monoclonal anti–IRAK-1 antibody was ob-
tained from Santa Cruz Biotechnology, Inc., and the rabbit polyclonal anti–
IRAK-1 antibody plus the corresponding blocking peptide was from 
LabVision Corporation. The NF-κB reporter construct pBIIX-luciferase 
carrying two copies (2× NF-κB) of the κB sequences from the Igκ enhancer 
was provided by S. Ghosh (Yale University Medical School, New Haven, 
CT). The dominant-negative and wild-type IRAK-1 expression construct 
was provided by M. Muzio (Instituto di Ricerche Farmacologiche Mario 
Negri, Milano, Italy) and Amgen, respectively. The ubiquitin expression 
plasmid was provided by K. Lindsten (Karolinska Institute, Stockholm, 
  Sweden). Murine recombinant IL-1β was purchased from Nordic Biosite, 
and TNF was from R&D Systems. Escherichia coli K12 D31m4 LPS was 
  ordered from List Biological Laboratories. Purity of the LPS preparation was 
confi  rmed by complete absence of stimulating activity on peritoneal macro-
phages isolated from TLR4-defi  cient mice and preserved potency after re-
peated phenol-chloroform extractions (not depicted). LPS was quantifi  ed 
using the chromogenic QCL-1000 limulus amebocyte lysate system from 
BioWhittaker. S. typhimurium LPS and brefeldin A were purchased from 
Sigma-Aldrich. The kinase inhibitor K-252b was purchased from Alexis 
Biochemicals. The chemokines MIP-2, TNF, and KC were quantifi  ed using 
commercial ELISAs from Nordic Biosite and R&D Systems, respectively. 
Rat tail collagen was ordered from Institute Jacques Boy. Cell culture 
  reagents were all from Gibco Life Technologies if not stated otherwise.
Mice and primary cell isolation. C57BL/6 mice were purchased from 
Charles River Breeding Laboratories, housed under specifi  c pathogen-free 
conditions, and treated in accordance with the local animal protection legisla-
tion (Regierungspräsidium Stuttgart). The TLR4-defi  cient C57BL/10ScN 
mice were provided by M. Freudenberg (Max Planck-Institute of Immuno-
biology, Freiburg, Germany). Mice were killed and the small intestine was 
removed and extensively rinsed with ice-cold PBS. The intestinal epithelium 
was separated from the underlying tissue by incubation in 30 mM EDTA in 
Ca2+- and Mg2+-free PBS for 10 min at 37°C followed by vigorous shaking. 
Cells were harvested by centrifugation, washed, and multicellular epithelial 
aggregates were purifi  ed by repeated diff  erential sedimentation at 1g in ice-cold 
PBS from contaminating cells and residual tissue. Viability of adult primary 
IECs was illustrated by rapid phosphorylation of STAT6 upon incubation in 
the presence of 10 ng/ml IL-4 or IL-13 (not depicted). Small intestinal tissue 
of neonatal mice was obtained from spontaneously delivered newborns. 
  Caesarean section was performed with full-term gravid females, and newborn 
mice were killed immediately or kept separately under infrared light for 2 h 
after delivery. Intestinal macrophages were separated from EDTA-treated in-
testinal tissue using a 100-μm nylon cell strainer (BD Falcon) and enriched by 
adhesion to plastic cell culture plates for 2 h at 37°C. Blood monocytes were 
obtained from newborn mice, and cytokine secretion was determined in a 
whole blood assay. Peritoneal macrophages were harvested after intraperito-
neal injection of sterile 4% Brewer’s thioglycolate broth (Sigma-Aldrich).
Cell culture and stimulation assays. Primary IECs were cultured in a 
modifi   ed, hormonally defi   ned medium with DMEM and F12 (vol 1:1) 
  supplemented with 5% FCS (PAA), 2% glucose, 20 mM Hepes, 2 mM 
  glutamin, 5 μg/ml insulin, 50 nM dexamethasone, 60 nM sodium selenite, 
10 ng/ml epithelial growth factor, 5 μg/ml transferrin, and 1 nM 3,3′,5-
  triiodo-l-thyronine sodium salt as described previously (38). To prevent mi-
crobial growth, 100 U/ml penicillin, 100 μg/ml streptomycin, and 2.5 
μg/ml amphotericin B (Sigma-Aldrich) were added. Cells were incubated at 
37°C in a 5% CO2/95% humidity air atmosphere on collagen-coated cell 
culture dishes. Primary intestinal macrophages or blood monocytes were 
cultured in RPMI 1640 medium supplemented with 5% FCS (PAA), 100 
U/ml penicillin, and 100 μg/ml streptomycin (Invitrogen). Murine small 
intestinal epithelial m-ICcl2 cells were cultured as described previously (6, 39). 
RAW 264.7 cells were obtained from the American Type Culture Collec-
tion and propagated in RPMI 1640 medium (Invitrogen) supplemented 
with 20 mM Hepes, 2 mM l-glutamine, and 10% FCS. Plasmid DNA was 
prepared using the EndoFree Plasmid kit from QIAGEN, and transfection 
was performed using Lipofectamine 2000 reagent (Invitrogen) according to 
the manufacturer’s instructions. Stimulation was performed by the addition 
of 50 ng/ml TNF, 100 ng/ml IL-1β, or LPS at the indicated concentrations. 
Cell culture supernatants were harvested after 12 h and stored at −20°C until 
further analysis. For kinase inhibition, m-ICcl2 cells were preincubated for 
40 min in the presence of 25 μM K-252b and subsequently stimulated with 
100 ng/ml LPS for 2 h. 5 μg of total cell lysate was analyzed by Western blot 
for the presence of IRAK-1.
Immunofl  uorescence staining of cells and tissue sections. Staining of 
primary IECs for ZO-1 and E-cadherin was performed using a rabbit anti–
ZO-1 antiserum (Zymed Laboratories) and the mouse monoclonal IgG2a 
anti–E-cadherin antibody (BD Transduction Laboratories), respectively, 
  followed by the appropriate Cy3-conjugated secondary antibodies (Jackson 
  ImmunoResearch Laboratories). Actin staining in primary IECs was per-
formed by incubation with FITC-phalloidin 1:200 (Sigma-Aldrich) for 10 min. 
Immunolabeling of internalized S. typhimurium LPS was performed after fi  xa-
tion in 3.5% paraformaldehyde and permeabilization with 0.5% saponin using 
two mouse monoclonal anti-O4 and anti-O5 antibodies simultaneously, 
  followed by incubation with a Cy3-conjugated goat anti–mouse secondary 
antibody (Jackson ImmunoResearch Laboratories). Intracellular staining for 
MIP-2 in primary IECs was performed after permeabilization with 0.5% 
  saponin after a 6-h incubation with 0.5 μg/ml brefeldin A. Bound MIP-2 
antibodies were detected using a goat anti–rabbit Cy3-conjugated antibody 
(Jackson ImmunoResearch Laboratories). Cellular distribution of the NF-κB 
subunit p65 in situ was analyzed by immunofl  uorescence using a rabbit anti–
NF-κB p65 antiserum (Santa Cruz Biotechnology, Inc.). Cryosections were 
acetone-fi   xed, blocked with 10% normal donkey serum, and incubated 
with primary antibody at a 1:50 dilution for 1 h. After washing, antibody 
binding was visualized using a Texas Red–conjugated donkey anti–rabbit 
antiserum (Jackson ImmunoResearch Laboratories). Immunostaining for 
CD45+ cells was performed using biotin-conjugated rat anti-CD45 anti-
bodies in combination with FITC-labeled streptavidin (BD Biosciences). 
Vectashield-mounted slides (Vector Laboratories) were visualized using an 
ApoTome-equipped Axioplan 2 microscope connected to an AxioCam Mr 
digital camera (Carl Zeiss MicroImaging, Inc.). Immunostaining of phos-
phorylated IκB-α in paraformaldehyde-fi  xed intestinal tissue sections was 
performed using a phospho–IκB-α Ser32/36-specifi  c mouse monoclonal 
antibody (Cell Signaling Technology) exactly as   described in the manufac-
turers’ recommendations. The Vectastain Elite ABC-kit (Vector Labora-
tories) in combination with a biotinylated goat anti–mouse (Fab′)2 antiserum 
(Jackson ImmunoResearch Laboratories) and the DAB substrate kit with 
3′,3′-diaminobenzidine (Vector Laboratories) was used for visualization.
Immunoblotting and immunoprecipitation. Cell lines and isolated pri-
mary IECs were resuspended in lysis buff  er (3:1 WB/SB vol/vol; SB: 250 
mM Tris, pH 6.5, 8% SDS, 40% glycerol; WB: 50 mM Tris, pH 7.4, 120 
mM NaCl) supplemented with a proteinase inhibitor cocktail (Complete JEM VOL. 203, April 17, 2006  983
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Mini; Roche Diagnostics). Intestinal tissue was grinded to powder in liquid 
nitrogen and subsequently resuspended in 200 μl lysis buff  er. Samples were 
sonifi  ed and the protein concentration was determined (DC Protein Assay; 
Bio-Rad Laboratories). For immunoprecipitation, cells were transfected 
with an ubiquitin expression plasmid 24 h before LPS stimulation (100 ng/ml, 
0.5 h). Unstimulated and stimulated cells were lysed in buff  er I (50 mM 
Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% Nonidet P-40, 0.25% sodium-
  deoxycholate, proteinase inhibitor cocktail), sonifi  ed, centrifuged, and pre-
cleared with 50 μl protein G sepharose (GE Healthcare) for 3 h at 4°C. 1 μg 
mouse monoclonal anti-ubiquitin antiserum (Sigma-Aldrich) was added to 
the precleared supernatant for 1 h at 4°C, followed by the addition of 50 μl 
protein G sepharose and incubation overnight at 4°C. Bound protein was 
washed twice in lysis buff  er (I), followed by two washing steps in buff  er II 
(similar to buff  er I, but 250 mM NaCl, 0.1% Nonidet P-40, 0.025% sodium-
deoxycholate) and one washing step in buff  er III (similar to buff  er I, but 
0.1% Nonidet P-40, 0.025% sodium-deoxycholate). Protein was eluted in 
loading buff  er and separated on a 10% acrylamide gel and blotted on nitro-
cellulose. Membranes were incubated overnight at 4°C with the primary an-
tibody at the recommended concentration. Detection was performed using 
peroxidase-labeled goat anti–mouse or goat anti–rabbit secondary antibodies 
(Jackson ImmunoResearch Laboratories) in combination with the ECL kit 
(GE Healthcare). Before restaining, membranes were stripped for 45 min at 
50°C in 62.5 mM Tris HCl, pH 6.7, 100 mM β-mercaptoethanol, and 2% 
SDS, followed by three 15-min washing steps.
Flow cytometry. Before fl  ow cytometry, ex vivo–isolated primary IEC 
aggregates were trypsinized to obtain single cell suspensions. Analysis for 
contaminating hematopoietic cells was performed using FITC-conjugated 
anti-CD3 and anti-CD11b, PE-conjugated anti-B220, and biotin- conjugated 
anti-CD45 antibodies as well as APC-conjugated streptavidin (all purchased 
from BD Biosciences). Apoptosis was determined using FITC-annexin (BD 
Biosciences) according to the manufacturer’s protocol. TLR4/MD-2 
  expression was visualized using a goat anti–rat FITC-conjugated secondary 
antibody (Jackson ImmunoResearch Laboratories) after fi  xation (Cytofi  x; 
BD Biosciences) with or without permeabilization in Ca2+- and Mg2+-free 
PBS containing 0.5% saponin and 2% FCS. Rat anti-haemagglutinin mono-
clonal antibodies (Boehringer) were used as isotype control. MIP-2 pro-
duction was determined by intracellular cytokine staining after a 6-h 
  incubation with 0.5 μg/ml brefeldin A (Sigma-Aldrich) in the presence or 
absence of 100 ng/ml LPS. Primary IECs were then trypsinized, fi  xed 
  (Cytofi  x; BD Biosciences), and permeabilized. Cells were incubated on ice 
with rabbit anti–MIP-2 antiserum (1:100; Nordic Biosite) in PBS, 1% FCS 
and 0.5% saponin, and then washed and stained using a goat Cy5- conjugated 
anti–rabbit IgG (Jackson ImmunoResearch Laboratories). An isotype 
monoclonal mouse IgG2a antibody was used as isotype control for the 
anti–E-cadherin antibody (BD Biosciences). Intestinal macrophages were 
characterized using PE-conjugated anti-CD45, anti-BM8, and anti-CD40 
as well as biotin-  conjugated anti-B7.1 antibodies in combination with 
streptavidin-PE (BD Biosciences). Cells were analyzed on a FACSCalibur 
apparatus (BD Biosciences).
Laser microdissection and RT-PCR analysis. Total epithelial RNA was 
isolated from intestinal tissue by laser microdissection (AS LMD; Leica) us-
ing a standard protocol. In brief, 10-μm sections from snap-frozen intestinal 
tissue were placed on RNase ZAP (Sigma-Aldrich) -pretreated PET frame 
slides, air-dried, fi  xed, and stained with 0.1% toluidine blue in DEPC   water. 
Epithelial cells were collected and subjected to RNA isolation (RNeasy 
  Micro kit; QIAGEN). Total RNA from small intestinal tissue or primary 
IEC preparations was isolated using TRIzol reagent (Invitrogen) according to 
the manufacturer’s protocol. cDNA was synthesized from total mRNA using 
oligo(dT)18 primer from the fi  rst-strand cDNA synthesis AMV kit (Roche). 
The following primers were used for DNA amplifi  cation: β2 microglobulin 
(forward: 5′-G  C  T  C  G  G  T  G  A  C  C  C  T  G  G  T  C  T  T  T  -3′, reverse: 5′-A  A  T  G  T-
G  A  G  G  C  G  G  G  T  G  G  A  A  C  T  -3′);  Hprt (forward: 5′-T  G  A  T  C  A  G  T  C  A  A  C  G-
G  G  G  G  A  C  A  -3′, reverse: 5′-T  T  C  G  A  G  A  G  G  T  C  C  T  T  T  T  C  A  C  C  A  -3′); Tlr4 
(forward: 5′-T  G  G  C  T  C  C  T  G  G  C  T  A  G  G  A  C  T  C  T  G  -3′, reverse: 5′-T  C  T  T-
C  A  A  G  G  G  G  T  T  G  A  A  G  C  T  C  A  G  -3′); Md-2 (forward: 5′-T  G  C  A  A  C  T  C  C  T-
C  C  G  A  T  G  C  A  A  T  -3′, reverse: 5′-T  T  C  C  T  T  A  C  G  C  T  T  C  G  G  C  A  A  C  T  C  -3′); 
Tollip (forward: 5′-G  C  A  G  G  G  T  G  T  T  G  G  C  T  A  T  G  T  G  C  -3′, reverse: 5′-T  C-
C  C  T  G  T  C  C  A  T  G  T  T  G  G  G  A  A  A  -3′); Sigirr (forward: 5′-G  C  T  G  A  C  C  T  C  C  T-
G  A  T  G  G  C  T  G  A  -3′, reverse: 5′-G  C  A  G  G  G  C  G  A  G  C  A  A  G  A  A  G  T  C  -3′); ST-2 
(forward: 5′-T  C  C  C  A  T  G  T  A  T  T  T  G  A  C  A  G  T  T  A  C  G  G  -3′, reverse: 5′-C  A  G  C-
T  T  G  G  C  G  G  C  T  T  T  T  T  A  T  G  -3′); Irak-1 (forward: 5′-G  A  G  G  A  T  C  A  G  C  T  C  C-
A  C  C  T  T  C  A  -3′, reverse: 5′-G  G  G  T  A  C  C  T  C  G  A  A  C  T  G  T  G  G  A  A  -3′);  Cd45 
(forward: 5′-G  C  T  C  A  A  A  C  T  T  C  T  G  G  C  C  T  T  T  G  -3′, reverse: 5′-A  G  C  A  C  A  T-
G  T  T  T  G  C  T  T  C  G  T  T  G  -3′); and Myd88/sMyD88 (forward: 5′-A  G  A  G  C  T  G  C-
T  G  G  C  C  T  T  G  T  T  A  G  -3′, reverse: 5′-T  C  A  T  C  T  C  C  T  G  C  A  C  A  A  A  C  T  C  G  -3′). 
The MyD88 primers used were designed to span the domain that is missing in 
the short form of MyD88 (sMyD88) and therefore resulted in a 266- or 130-
nucleotide-long amplifi  cate for the complete or alternatively spliced short 
form of MyD88, respectively, as published previously (18). All primers used 
in this study were intron spanning as demonstrated by the absence of amplifi  -
cation from genomic DNA. Sequencing of all PCR products confi  rmed the 
specifi  city of the primers used. For quantitative mRNA analysis, the reaction 
mixture was prepared using 2× Taqman Universal Mastermix (Applied Bi-
osystems), sample cDNA, intron-spanning forward and reverse primers, as 
well as the 6-carboxy-fl  uorescein–conjugated target probe provided in the 
commercial TaqMan gene expression assay for murine hypoxanthine phos-
phoribosyltransferase (HPRT) and MIP-2 (Applied Biosystems). PCR am-
plifi  cation and detection were performed using an ABI Prism 7900 sequence 
detector (Applied Biosystems) according to the manufacturer’s instructions. 
Each sample was amplifi  ed in triplicate and normalized to the endogenous 
HPRT control. Values are indicated as relative quantities (RQs) to the cali-
brator sample represented by the fetal or postnatal intestinal tissue sample ± 
the minimal and maximal RQ value of the measurement.
Statistical analysis. Results are given as the mean ± SD. Statistical 
analyses were performed using the Student’s t test. A p-value <0.05 was 
considered signifi  cant.
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